Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RTW Biotech portfolio co Aktis Oncology raises $318m in IPO

(Sharecast News) - Life sciences investor RTW Biotech Opportunities said its private portfolio company Aktis Oncology had raised $318m via an IPO. Aktis offered 17.65 million shares at $18 each, representing a 2.6% step-up from RTW Bio's prior holding value at November 30 and a18.3% step-up from the cost at the time of purchase in September 2024.

Aktis started trading on the Nasdaq global select market on January 9, where the stock traded up 24.4% to close at $22.40 per share.

The clinical-stage oncology company is focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations. Its lead programme targets Nectin-4, a miniprotein radioconjugate with multi-indication potential across multiple tumour types, RTW said on Monday.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Air France-KLM submits bid for stake in Portugal's TAP
(Sharecast News) - Air France-KLM said it had submitted a non-binding offer to buy a minority stake in TAP Air Portugal as part of the Portuguese government's plan to privatise its national airline.
Sorted Group proposes to dispose of its main trading subsidiary
(Sharecast News) - Sorted Group announced a proposal to dispose of its main trading subsidiary Sorted Group Limited on Thursday, for a nominal £1, in a move that would see the company become an AIM cash shell and pursue a new acquisition-led strategy.
Speedy Hire warns on worsening market conditions despite strategic progress
(Sharecast News) - Tools and equipment hire company Speedy Hire said on Thursday that it had delivered "significant strategic progress" in FY26, highlighted by its "transformational" partnership with Proservice and continued momentum across its core operations, but also cautioned that trading conditions had deteriorated further in the final quarter amid budget uncertainty, geopolitical tensions and customer‑driven delays.
RBC Capital Markets upgrades Berkeley to 'outperform'
(Sharecast News) - Analysts at RBC Capital Markets upgraded housebuilder Berkeley from 'sector perform' to 'outperform' on Thursday, noting the group had "acted decisively" to the challenges it had faced.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.